Live polio vaccine exposure while receiving anti-TNF therapy for reactive arthritis

International Journal of Rheumatic Diseases

Volumn 13, Issue 2, 2010, Pages 184-186

  Badsha, Humeira ^a   Daher, Mirna ^a   Edwards, Christopher J ^b  

^a Dubai Bone and Joint Center   (United Arab Emirates)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Anti TNF; Polio vaccine; Vaccine

Indexed keywords

ETANERCEPT; POLIOMYELITIS VACCINE; ANTIRHEUMATIC AGENT; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; ORAL POLIOMYELITIS VACCINE; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG POTENCY; DRUG WITHDRAWAL; HUMAN; IMMUNOCOMPETENCE; INFECTION; MALE; PATIENT COUNSELING; PRACTICE GUIDELINE; PRIORITY JOURNAL; REACTIVE ARTHRITIS; RISK BENEFIT ANALYSIS; SYMPTOM; ANTAGONISTS AND INHIBITORS; ARTHRITIS, REACTIVE; CONTRAINDICATIONS; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; VACCINATION;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, REACTIVE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; MALE; POLIOVIRUS VACCINE, ORAL; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION;

EID: 77953790582     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2010.01466.x     Document Type: Article

References (8)

1. Saag KG, Teng GG, Patkar NM. Recommendations for the use of Biological and Non-Biological Drugs in Rheumatoid Arthritis. 2008
2. Recommended adult immunization schedule: United States, 2009. Ann Intern Med 2009, 150:40-4. Abstract
3. Progress towards interruption of wild poliovirus transmission, January 2004 to March 2005. WER 2005, 80.
4. Product Approval Information. http://www.fda.gov/cber/products/kinrix.htm, Available at: Accessed on August 13, 2008
5. Alexander LN, Seward JH, Santibanez TA. Vaccine policy changes and epidemiology of poliomyelitis in the United States. JAMA 2004, 292:1696.
6. Henderson DA, Witte JJ, Morris L, Langmuir AD. PAralytic disease associated with oral polio vaccines. JAMA 1964, 190:41.
7. Solomon DH, Lunt M, Schneeweiss S. The risk of infection associated with tumor necrosis factor alpha antagonists: making sense of epidemiologic evidence. Arthritis Rheum 2008, 58:919.
8. Listing J, Strangfeld A, Kary S. Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum 2005, 52:3403.